Dr. Daniel Arango, MD

Dr. Arango practices at Houston Methodist Hospital in Houston, Texas, part of Houston Methodist.

Dr. Arango's NPI, 1205255478, was assigned on April 15, 2014. Dr. Arango graduated from UTMB Health in 2014. Dr. Arango holds Texas license T7482.

Dr. Arango's primary practice is Houston Methodist Hospital, at 6565 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 790-2221.

Dr. Arango's primary practice is Houston Methodist Hospital in Houston, Texas, part of Houston Methodist. Dr. Arango is also affiliated with John Sealy Hospital. The medical group on file is US Anesthesia Partners. Dmand AI also links Dr. Arango to 2 more medical groups and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arango practices, 3 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Arango's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Arango is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Arango's licenses on file in 2 states: Texas and Louisiana.

CMS data shows 56 Medicare services from Dr. Arango across 2 procedure codes in 2022, for 54 Medicare patients. Medicare paid $3,165 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 54 Medicare patients who saw Dr. Arango in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Arango's median patient age at 63, with 47% women.

In 2019, Dr. Arango wrote 22 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $314 in total drug cost. In 2017, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Arango for performance year 2024, reported as part of a group. Dr. Arango accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Arango, published from 2012 to 2025. 2024 was the busiest year, with 5. The most frequent topics are RNA, Messenger, Cytidine and Apigenin. Dr. Arango has published most often in bioRxiv. Dr. Arango's most frequent co-authors are Amit Kumar Aggarwal, DO, Grant D. Barish, MD and Bledi Brahimaj, MD.

CMS Open Payments shows 7 general payments to Dr. Arango from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $100.

Dr. Arango graduated from UTMB Health in 2014.

Dr. Arango is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.